Triple-negative breast cancer (TNBC) or basal phenotype [11] encompasses a breast tumor subtype that is clinically negative for the expression of the estrogen (ER) and progesterone (PR) receptors and lacks overexpression of the Human Epidermal Growth Factor Receptor 2 (HER2) protein [12]. Here, ERBB2 is linked to breast neoplasm.